Cyclerion holders approve 1-for-7 reverse split and merger stock issuance, reject redomestication
Cyclerion shareholders approved the share issuance tied to the Merger, a 1-for-7 reverse stock split, and an increase in authorized shares to 700,000,000 at a meeting on August 26, 2026. They did not approve the proposal to move the company's domicile to the Cayman Islands, so the combined company will remain a Massachusetts corporation. The Cayman move was not a condition to closing the Merger.
Key points
- Reverse stock split of 1-for-7 approved with 3,877,744 votes for and 18,003 against; the combined company is expected to trade as KRSA on Nasdaq at the open on September 9, 2026
- Merger-related Nasdaq stock issuance approved with 3,392,645 votes for and 3,730 against
- Redomestication to the Cayman Islands not approved: 2,099,051 for and 1,296,575 against, short of the required vote
- Quorum was 3,896,779 of 4,681,351 shares entitled to vote, based on the July 17, 2026 record date
The filing
Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 27, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.